PERFIL DEMOGRÁFICO E EPIDEMIOLÓGICO DA COVID-19 LONGA: REVISÃO DE ESCOPO
DOI:
https://doi.org/10.31011/reaid-2025-v.99-n.4-art.2505Palavras-chave:
Síndrome de Covid-19 Pós-Aguda, Sinais e Sintomas, Fatores de RiscoResumo
Introdução: em 2023, a Organização Mundial de Saúde (OMS) declarou o término da emergência de saúde pública global da doença do novo coronavírus (COVID-19), no entanto, um número crescente de pacientes tem manifestado sintomas prolongados da após a infecção viral. Objetivo: mapear as evidências científicas sobre os sintomas de COVID-19 longa, considerando o perfil demográfico, epidemiológico e situação vacinal. Métodos: trata-se de uma revisão de escopo, as buscas foram realizadas nas bases LILACS, PubMed, SCOPUS, Web of Science, SCIELO e LitCovid. Resultados: foram selecionados 27 artigos, evidenciando o desenvolvimento da COVID longa em diversas faixas etárias, uma maior prevalência entre o sexo feminino. A presença de comorbidades e hospitalização foram associados ao desenvolvimento da COVID longa e a vacinação contra a COVID-19 foi considerada um fator protetor. Os sintomas frequentemente observados foram a fadiga, falta de ar, distúrbios do sono, alterações na memória ou concentração e alterações no olfato ou paladar. Conclusão: esta análise mostrou os sintomas mais frequentes da COVID longa como fadiga, falta de ar, distúrbios do sono, alterações na memória ou concentração e alterações no olfato ou paladar, além de faixa etária variada e ser do sexo feminino. Ainda, pessoas com comorbidades e não vacinadas apresentaram maior risco de desenvolver a COVID longa.
Downloads
Referências
Emecen AN, Keskin S, Turunc O, Suner AF, Siyve N, Sensoy EB, et al. The presence of symptoms within 6 months after COVID-19: a single-center longitudinal study. Ir J Med Sci [Internet]. 2023 [cited 2024 Nov 4];192(2):741-50. DOI: https://doi.org/10.1007/s11845-022-03072-0 DOI: https://doi.org/10.1007/s11845-022-03072-0
Miranda DAP, Gomes SVC, Filgueiras PS, Corsini CA, Almeida NBF, Silva RA, et al. Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Trans R Soc Trop Med Hyg [Internet]. 2022 [cited 2024 Nov 4];116(11):1007-14. DOI: https://doi.org/10.1093/trstmh/trac030 DOI: https://doi.org/10.1093/trstmh/trac030
Yelin D, Margalit I, Yahav D, Runold M, Bruchfeld J. Long COVID-19-it's not over until? Clin Microbiol Infect [Internet]. 2021 [cited 2024 Nov 4];27(4):506-8. DOI: https://doi.org/10.1016%2Fj.cmi.2020.12.001 DOI: https://doi.org/10.1016/j.cmi.2020.12.001
Kenny G, Townsend L, Savinelli S, Mallon PWG. Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets. Front Mol Biosci [Internet]. 2023 [cited 2024 Nov 6];10:1157651. DOI: https://doi.org/10.3389/fmolb.2023.1157651 DOI: https://doi.org/10.3389/fmolb.2023.1157651
Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, Alexandre L, et al. JBI Manual for Evidence Synthesis. JBI [Internet]. 2024 [cited 2024 Nov 8]. DOI: https://doi.org/10.46658/JBIMES-24-01 DOI: https://doi.org/10.46658/JBIMES-24-01
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet]. 2021 [cited 2024 Nov 8];372:n71. DOI: https://doi.org/10.1136/bmj.n71 DOI: https://doi.org/10.1136/bmj.n71
Fabbri S, Silva C, Hernandes E, Octaviano F, Di Thommazo A, Belgamo A. Improvements in the StArt tool to better support the systematic review process [Internet]. 2016 [cited 2024 Nov 6]. Available from: https://www.lapes.ufscar.br/re-sources/tools-1/start-1 DOI: https://doi.org/10.1145/2915970.2916013
Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun [Internet]. 2021 [cited 2024 Nov 11]; 12(1):6571. DOI: https://doi.org/10.1038/s41467-021-26513-3 DOI: https://doi.org/10.1038/s41467-021-26513-3
Arjun M, Singh AK, Amigo D, Das K, G A, Venkateshan M, et al. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19. PLoS One [Internet]. 2022 [cited 2024 Nov 11]; 17(12):e0278825. DOI: https://doi.org/10.1371%2Fjournal.pone.0278825 DOI: https://doi.org/10.1371/journal.pone.0278825
Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ [Internet]. 2022 [cited 2024 Nov 5]; 377:e069676. DOI: https://doi.org/10.1136/bmj-2021-069676 DOI: https://doi.org/10.1136/bmj-2021-069676
Han JH, Womack KN, Tenforde MW, Files DC, Gibbs KW, Shapiro NI, et al. Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza Other Respir Viruses [Internet]. 2022 [cited 2024 Nov 12]; 16(4):680-9. DOI: https://doi.org/10.1111/irv.12980 DOI: https://doi.org/10.1111/irv.12980
Peghin M, Martino M, Palese A, Gerussi V, Bontempo G, Graziano E, et al. Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clin Microbiol Infect [Internet]. 2022 [cited 2024 Nov 12];28(8):1140-8. DOI: https://doi.org/10.1016/j.cmi.2022.03.016 DOI: https://doi.org/10.1016/j.cmi.2022.03.016
Hamdh BA, Nazzal Z. A prospective cohort study assessing the relationship between long-COVID symptom incidence in COVID-19 patients and COVID-19 vaccination. Sci Rep [Internet]. 2023 [cited 2024 Nov 13];13(1):4896. DOI: https://doi.org/10.1038/s41598-023-30583-2 DOI: https://doi.org/10.1038/s41598-023-30583-2
Brunvoll SH, Nygaard AB, Fagerland MW, Holland P, Ellingjord-Dale M, Dahl JA, et al. Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection. Int J Infect Dis [Internet]. 2023 [cited 2024 Nov 15];126:10-3. DOI: https://doi.org/10.1016/j.ijid.2022.11.009 DOI: https://doi.org/10.1016/j.ijid.2022.11.009
Dennis A, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Eichert N, et al. Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study. J R Soc Med [Internet]. 2023 [cited 2024 Nov 15];116(3):97-112. DOI: https://doi.org/10.1177/01410768231154703 DOI: https://doi.org/10.1177/01410768231154703
Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P, et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ [Internet]. 2023 [cited 2024 Nov 17];380:e072529. DOI: https://doi.org/10.1136/bmj-2022-072529 DOI: https://doi.org/10.1136/bmj-2022-072529
Morioka S, Tsuzuki S, Maruki T, Terada M, Miyazato Y, Kutsuna S, et al. Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study. Public Health [Internet]. 2023 [cited 2024 Nov 17];216:39-44. DOI: https://doi.org/10.1016/j.puhe.2023.01.008 DOI: https://doi.org/10.1016/j.puhe.2023.01.008
Nehme M, Vetter P, Chappuis F, Kaiser L, Guessous I; CoviCare Study Team. Prevalence of post-coronavirus disease condition 12 weeks after omicron infection compared with negative controls and association with vaccination status. Clin Infect Dis [Internet]. 2023 [cited 2024 Nov 18];76(9):1567-75. DOI: https://doi.org/10.1093/cid/ciac947 DOI: https://doi.org/10.1093/cid/ciac947
Tene L, Bergroth T, Eisenberg A, David SSB, Chodick G. Risk factors, health outcomes, healthcare services utilization, and direct medical costs of patients with long COVID. Int J Infect Dis [Internet]. 2023[cited 2024 Nov 20];128:3-10. DOI: https://doi.org/10.1016/j.ijid.2022.12.002 DOI: https://doi.org/10.1016/j.ijid.2022.12.002
Wong MC, Huang J, Wong YY, Wong GL, Yip TC, Chan RN, et al. Epidemiology, symptomatology, and risk factors for long COVID symptoms: population-based, multicenter study. JMIR Public Health Surveill [Internet]. 2023 [cited 2024 Nov 20];9:e42315. DOI: https://doi.org/10.2196%2F42315 DOI: https://doi.org/10.2196/42315
Aldahleh H, Batieha A, Elayyan R, Abdo N, Abuzayed I, Albaik S, et al. Clinical profile, prognosis and post COVID-19 syndrome among UNRWA staff in Jordan: a clinical case-series study. PLoS One [Internet]. 2023 [cited 2024 Nov 20];18(11):e0293023. DOI: https://doi.org/10.1371/journal.pone.0293023 DOI: https://doi.org/10.1371/journal.pone.0293023
Karuna S, Gallardo-Cartagena JA, Theodore D, Hunidzarira P, Montenegro-Idrogo J, Hu J, et al. HVTN 405/HPTN 1901 study team. Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region. J Glob Health [Internet]. 2023 [cited 2024 Nov 20];13:06020. DOI: https://doi.org/10.7189/jogh.13.06020 DOI: https://doi.org/10.7189/jogh.13.06020
Reme BA, Gjesvik J, Magnusson K. Preditores da condição pós-COVID após infecção leve por SARS-CoV-2. Nat Commun [Internet]. 2023 [citado 2024 Nov 25];14:5839. DOI: https://doi.org/10.1038/s41467-023-41541-x DOI: https://doi.org/10.1038/s41467-023-41541-x
Sahanic S, Tymoszuk P, Luger AK, Hüfner K, Boehm A, Pizzini A, et al. COVID-19 and its continuing burden after 12 months: a longitudinal observational prospective multicentre trial. ERJ Open Res [Internet]. 2023 [cited 2024 Nov 13];9(2):00317-22. DOI: https://doi.org/10.1183/23120541.00317-2022 DOI: https://doi.org/10.1183/23120541.00317-2022
Van Zon SKR, Ballering AV, Brouwer S, Rosmalen JGM; Lifelines Corona Research Initiative. Symptom profiles and their risk factors in patients with post-COVID-19 condition: a Dutch longitudinal cohort study. Eur J Public Health [Internet]. 2023 [cited 2024 Nov 30];33(6):1163-70. DOI: https://doi.org/10.1093/eurpub/ckad152 DOI: https://doi.org/10.1093/eurpub/ckad160.896
Asadi-Pooya AA, Nemati M, Shahisavandi M, Nemati H, Karimi A, Jafari A, et al. How does COVID-19 vaccination affect long-COVID symptoms? PLoS One [Internet]. 2024 [cited 2024 Nov 30];19(2):e0296680. DOI: https://doi.org/10.1371/journal.pone.0296680 DOI: https://doi.org/10.1371/journal.pone.0296680
Elias TP, Gebreamlak TW, Gebremeskel TT, Adde BL, Abie AS, Elias BP, et al. Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study. PLoS One [Internet]. 2024 [cited 2024 Dec 01];19(5):e0298409. DOI: https://doi.org/10.1371/journal.pone.0298409 DOI: https://doi.org/10.1371/journal.pone.0298409
Erinoso O, Osibogun O, Balakrishnan S, Yang W. Long COVID among US adults from a population-based study: Association with vaccination, cigarette smoking, and the modifying effect of chronic obstructive pulmonary disease (COPD). Prev Med [Internet]. 2024 [cited 2024 Dec 01];184:108004. DOI: https://doi.org/10.1016/j.ypmed.2024.108004 DOI: https://doi.org/10.1016/j.ypmed.2024.108004
Iversen A, Blomberg B, Haug K, Kittang B, Özgümüs T, Cox RJ, et al. Symptom trajectories of post-COVID sequelae in patients with acute Delta or Omicron infection in Bergen, Norway. Front Public Health [Internet]. 2024 [cited 2024 Dec 01];12:1320059. DOI: https://doi.org/10.3389/fpubh.2024.1320059 DOI: https://doi.org/10.3389/fpubh.2024.1320059
Kim Y, Bae S, Chang HH, Woo KS. Characteristics of long COVID and the impact of COVID-19 vaccination on long COVID 2 years following COVID-19 infection: prospective cohort study. Sci Rep [Internet]. 2024 [cited 2024 Dec 01];14:854. DOI: https://doi.org/10.1038/s41598-023-50024-4 DOI: https://doi.org/10.1038/s41598-023-50024-4
Lim SH, Lim YC, Zaki RA, Johari BM, Chang CY, Omar SFS, et al. Prevalence and predictors of post-acute COVID syndrome among infected healthcare workers at University Malaya Medical Centre. PLoS One [Internet]. 2024 [cited 2024 Dec 05];19(4):e0298376. DOI: https://doi.org/10.1371/journal.pone.0298376 DOI: https://doi.org/10.1371/journal.pone.0298376
Malden DE, Liu IA, Qian L, Sy LS, Lewin BJ, Asamura DT, et al. Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection. Nat Commun [Internet]. 2024 [cited 2024 Dec 05];15(1):4101. DOI: https://doi.org/10.1038/s41467-024-48022-9 DOI: https://doi.org/10.1038/s41467-024-48022-9
Romero-Ibarguengoitia ME, Rodríguez-Torres JF, Garza-Silva A. et al. Association of vaccine status, reinfections, and risk factors with Long COVID syndrome. Sci Rep [Internet]. 2024 [cited 2024 Dec 05];14:2817. DOI: https://doi.org/10.1038/s41598-024-52925-4 DOI: https://doi.org/10.1038/s41598-024-52925-4
Sárközi AT, Tornyi I, Békési E, Horváth I. Co-morbidity clusters in post-COVID-19 syndrome. J Clin Med [Internet]. 2024 [cited 2024 Dec 06];13(5):1457. DOI: https://doi.org/10.3390/jcm13051457 DOI: https://doi.org/10.3390/jcm13051457
Perumal R, Shunmugam L, Naidoo K, Wilkins D, Garzino-Demo A, Brechot C, et al. Biological mechanisms underpinning the development of long COVID. IScience [Internet]. 2023 [cited 2024 Dec 06];26(6):106935. DOI: https://doi.org/10.1016/j.isci.2023.106935 DOI: https://doi.org/10.1016/j.isci.2023.106935
Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol [Internet]. 2021 [cited 2024 Dec 10];12:698169. DOI: https://doi.org/10.3389/fmicb.2021.698169 DOI: https://doi.org/10.3389/fmicb.2021.698169
Baptista de Lima J, Salazar L, Fernandes A, Teixeira C, Marques L, Afonso C. Long COVID in Children and Adolescents: A Retrospective Study in a Pediatric Cohort. Pediatr Infect Dis J [Internet]. 2023 [cited 2024 Dec 10];42(4):e109-e111. DOI: https://doi.org/10.1097/INF.0000000000003829 DOI: https://doi.org/10.1097/INF.0000000000003829
Daitch V, Yelin D, Awwad M, Guaraldi G, Milić J, Mussini C, et al. Characteristics of long-COVID among older adults: a cross-sectional study. Int J Infect Dis [Internet]. 2022 [cited 2024 Dec 10];125:287-93. DOI: https://doi.org/10.1016/j.ijid.2022.09.035 DOI: https://doi.org/10.1016/j.ijid.2022.09.035
Feter N, Caputo EL, Leite JS, Delpino FM, Silva LSD, Vieira YP, et al. Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort. Cad Saúde Publica [Internet]. 2023 [cited 2024 Dec 10];39(12):e00098023. DOI: https://doi.org/10.1590/0102-311XEN098023 DOI: https://doi.org/10.1590/0102-311xen098023
Sylvester SV, Rusu R, Chan B, Bellows M, O'Keefe C, Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin [Internet]. 2022 [cited 2024 Dec 10];38(8):1391-9. DOI: https://doi.org/10.1080/03007995.2022.2081454 DOI: https://doi.org/10.1080/03007995.2022.2081454
Phillips S, Williams MA. Confronting Our Next National Health Disaster - Long-Haul Covid. N Engl J Med [Internet]. 2021 [cited 2024 Dec 11];385(7):577-9. DOI: https://doi.org/10.1056/nejmp2109285 DOI: https://doi.org/10.1056/NEJMp2109285
Sharma G, Volgman AS, Michos ED. Sex Differences in Mortality From COVID-19 Pandemic: Are Men Vulnerable and Women Protected? JACC Case Rep [Internet]. 2020 [cited 2024 Dec 15];2(9):1407-10. DOI: https://doi.org/10.1016/j.jaccas.2020.04.027 DOI: https://doi.org/10.1016/j.jaccas.2020.04.027
Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID risk - a signal to address sex hormones and women's health. Lancet Reg Health Eur [Internet]. 2021 [cited 2024 Dec 15];11:100242. DOI: https://doi.org/10.1016/j.lanepe.2021.100242 DOI: https://doi.org/10.1016/j.lanepe.2021.100242
Barreto APA, Barreto Filho MA, Duarte LC, Cerqueira-Silva T, Camelier A, Tavares NM, et al. Metabolic disorders and post-acute hospitalization in black/mixed-race patients with long COVID in Brazil: A cross-sectional analysis. PLoS One [Internet]. 2022 [cited 2024 Dec 15];17(10):e0276771. DOI: https://doi.org/10.1371/journal.pone.0276771 DOI: https://doi.org/10.1371/journal.pone.0276771
Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med [Internet]. 2023 [cited 2024 Dec 16];183(6):566-80. DOI: https://doi.org/10.1001/jamainternmed.2023.0750 DOI: https://doi.org/10.1001/jamainternmed.2023.0750
Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, et al. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis. Brain Behav Immun [Internet]. 2023 [cited 2024 Dec 17];111:211-29. DOI: https://doi.org/10.1016%2Fj.bbi.2023.03.022 DOI: https://doi.org/10.1016/j.bbi.2023.09.020
Arunachalam PS, Scott MKD, Hagan T, Li C, Feng Y, Wimmers F, et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature [Internet]. 2021 [cited 2024 Dec 17];596(7872):410-16. DOI: https://doi.org/10.1038%2Fs41586-021-03791-x DOI: https://doi.org/10.1038/s41586-021-03791-x
Gao P, Liu J, Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health [Internet]. 2022 [cited 2024 Dec 18];19(19):12422. DOI: https://doi.org/10.3390%2Fijerph191912422 DOI: https://doi.org/10.3390/ijerph191912422
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
